Ginkgo Bioworks Holdings, Inc. Share Price
Equities
DNA
US37611X1000
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8601 USD | +10.60% | -0.55% | -49.11% |
Sales 2024 * | 223M 17.87B | Sales 2025 * | 310M 24.8B | Capitalization | 1.72B 138B |
---|---|---|---|---|---|
Net income 2024 * | -631M -50.51B | Net income 2025 * | -534M -42.75B | EV / Sales 2024 * | 4.68 x |
Net cash position 2024 * | 676M 54.13B | Net cash position 2025 * | 550M 43.99B | EV / Sales 2025 * | 3.78 x |
P/E ratio 2024 * |
-2.69
x | P/E ratio 2025 * |
-3.17
x | Employees | 1,218 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.98% |
Latest transcript on Ginkgo Bioworks Holdings, Inc.
1 day | +10.60% | ||
1 week | -0.55% | ||
Current month | -25.85% | ||
1 month | -21.81% | ||
3 months | -33.33% | ||
6 months | -36.29% | ||
Current year | -49.11% |
Managers | Title | Age | Since |
---|---|---|---|
Austin Che
FOU | Founder | - | 31/12/07 |
Founder | - | 31/12/07 | |
Reshma Shetty
FOU | Founder | 43 | 31/12/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Henry
BRD | Director/Board Member | 56 | 15/09/21 |
Marijn Dekkers
CHM | Chairman | 65 | 15/09/21 |
Kathy Hannan
BRD | Director/Board Member | 62 | 01/08/22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.33% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 0.8601 | +10.60% | 71,222,534 |
25/04/24 | 0.7777 | -8.05% | 72,790,347 |
24/04/24 | 0.8458 | -2.84% | 45,516,704 |
23/04/24 | 0.8705 | +3.29% | 55,623,942 |
22/04/24 | 0.8428 | -2.56% | 51,997,262 |
Delayed Quote Nyse, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.11% | 1.72B | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- DNA Stock